Langlai Technology

About:

Langlai Technology is a clinical-stage innovative drug research and development company.

Website: https://www.createrna.com

Top Investors: Lilly Asia Ventures, Vinno Capital

Description:

Langlai Technology is a clinical-stage innovative drug research and development company. Adhering to the dual-drive strategy of synchronously improving the R&D pipeline and platform construction, it has built a full-process new drug R&D process from concept verification, candidate compound screening, preclinical druggability development to clinical research. system.

Total Funding Amount:

500M CNY

Headquarters Location:

Wuhan, Hubei, China

Founded Date:

2013-01-01

Contact Email:

BD(AT)createrna.com

Founders:

Number of Employees:

101-250

Last Funding Date:

2023-06-21

IPO Status:

Private

Industries:

© 2025 bioDAO.ai